👍_老虎社区_美港股上老虎

Yuenyee
2021-12-01

👍

3 Top Stocks That'll Make You Richer in December (and Beyond)<blockquote>12 月（及以后）让您更富有的 3 只热门股票</blockquote>

Bargains abound for growth and value investors.

3 Top Stocks That'll Make You Richer in December (and Beyond)<blockquote>12 月（及以后）让您更富有的 3 只热门股票</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":603321184,"tweetId":"603321184","gmtCreate":1638368421250,"gmtModify":1638368421533,"author":{"id":4087442949550080,"idStr":"4087442949550080","authorId":4087442949550080,"authorIdStr":"4087442949550080","name":"Yuenyee","avatar":"https://static.tigerbbs.com/b7436f5c582213fe37305f2b9b1e9ab3","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":15,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body>👍</body></html>","htmlText":"<html><head></head><body>👍</body></html>","text":"👍","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/603321184","repostId":1161855788,"repostType":4,"repost":{"id":"1161855788","kind":"news","pubTimestamp":1638368211,"share":"https://www.laohunote.com/m/news/1161855788?lang=zh_CN&edition=full","pubTime":"2021-12-01 22:16","market":"us","language":"en","title":"3 Top Stocks That'll Make You Richer in December (and Beyond)<blockquote>12 月（及以后）让您更富有的 3 只热门股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1161855788","media":"Motley Fool","summary":"Bargains abound for growth and value investors.","content":"We've officially hit the home stretch for what looks like another great year for the stock market. Since bottoming out in March 2020, the benchmark&nbsp;S&amp;P 500&nbsp;has been practically unstoppable. In what's become the strongest bounce-back rally from a bear-market bottom on record, the S&amp;P 500 has delivered a total return, including dividends, of 111% since March 23, 2020.<blockquote>我们已经正式进入股市又一个伟大的一年的冲刺阶段。自2020年3月触底以来，该基准标普500几乎势不可挡。自 2020 年 3 月 23 日以来，标普500从熊市底部出现了有记录以来最强劲的反弹，包括股息在内的总回报率为 111%。</blockquote> But even with the broader market a stone's throw from an all-time high, incredible deals still abound. The following three top stocks all possess attributes that can help make you richer in December, and, most importantly, well beyond.<blockquote>但即使大盘距离历史高点仅一箭之遥，令人难以置信的交易仍然比比皆是。以下三只顶级股票都拥有可以帮助您在 12 月变得更加富有的属性，最重要的是，可以帮助您在 12 月变得更加富有。</blockquote> <img src=\"https://static.tigerbbs.com/5d06d7202e9c1d1c4d748bc3e1a80774\" tg-width=\"2000\" tg-height=\"1334\" width=\"100%\" height=\"auto\">Image source: Getty Images.<blockquote>图片来源：盖蒂图片社。</blockquote> Sea Limited<blockquote>海有限公司</blockquote> For you unbridledgrowth investors, the stock that could make you a lot richer this month and well beyond is Singapore-based&nbsp;Sea Limited.<blockquote>对于你们这些肆无忌惮的成长型投资者来说，本月及以后可以让你们变得更加富有的股票是新加坡的股票海有限公司.</blockquote> Sea has had a monumental run-up since the bear-market bottom 20 months ago. Shares are up a cool 672% -- and that's after a 20% pullback from its all-time closing high on Oct. 19. With inflation picking up and coronavirus disease 2019 (COVID-19) variant concerns rearing their head, most growth stocks have taken it on the chin. But neither U.S. inflation nor COVID-19 variants are of concern to Sea Limited's three rapidly growing operating segments.<blockquote>自 20 个月前熊市底部以来，Sea 经历了巨大的上涨。该股在 10 月 19 日的历史收盘高点回调 20% 后上涨了 672%。随着通货膨胀加剧和冠状病毒疾病 2019 (COVID-19) 变种担忧抬头，大多数成长型股票都受到了影响。但美国通货膨胀和 COVID-19 变种都不是 Sea Limited 三个快速增长的运营部门的担忧。</blockquote> For the time being, the only division generating positive earnings before interest, taxes, depreciation, and amortization (EBITDA) is its mobile gaming unit, led byFree Fire. When the curtain closed on September, the company had 729 million quarterly active gamers.<blockquote>目前，唯一实现息税折旧摊销前利润 (EBITDA) 为正的部门是其移动游戏部门，由自由射击9 月份大幕落下时，该公司季度活跃玩家达到 7.29 亿。</blockquote> But it's not the number of gamers that's impressive. It's that 12.8% of these gamers (93.2 million) were paying to play. The pay-to-play conversion rate for the mobile gaming industry was closer to 2% in 2020.&nbsp; As long as Sea is generating revenue from users at a considerably higher clip than the industry average, it should command a valuation premium.<blockquote>但令人印象深刻的不是游戏玩家的数量。这些游戏玩家中有12.8%（9320万）是付费玩的。2020年，移动游戏行业的付费游戏转化率接近2%。只要Sea从用户那里获得的收入远高于行业平均水平，它就应该获得估值溢价。</blockquote> The second rapidly growing segment is digital financial services. Though this division is still relatively nascent, the number of paying mobile wallet users grew to 39.3 million in the third quarter. Since many of the regions targeted by Sea are underbanked emerging markets, offering digital financial tools that can democratize the payment process&nbsp;could be a long-term game-changer.<blockquote>第二个快速增长的细分市场是数字金融服务。尽管这一部门仍相对新生，但第三季度付费移动钱包用户数量增长至3930万。由于 Sea 的许多目标地区都是银行服务不足的新兴市场，因此提供能够使支付流程民主化的数字金融工具可能会改变游戏规则。</blockquote> But the third and&nbsp;most exciting operating segment&nbsp;is its e-commerce division, Shopee. Among downloadable shopping apps, Shopee consistently reigns supreme in Southeastern Asia. Between COVID-19 keeping people in their homes and middle-class consumers fueling buying activity in emerging market economies, Shopee is set up for success. In fact, its annual gross merchandise value (GMV) run-rate of $67.2 billion (based on third-quarter 2021 figures) is more than six times higher than the GMV the company reported in all of 2018.<blockquote>但第三个也是最令人兴奋的运营部门是其电子商务部门 Shopee。在可下载的购物应用中，Shopee在东南亚一直占据主导地位。在 COVID-19 让人们呆在家里和中产阶级消费者推动新兴市场经济体的购买活动之间，Shopee 注定要取得成功。事实上，其年度商品总价值 (GMV) 运行率为 672 亿美元（基于 2021 年第三季度数据），是该公司 2018 年全年报告的 GMV 的六倍多。</blockquote> Sea Limited could very well be one of the fastest-growing mega-cap stocks on the planet this decade.<blockquote>Sea Limited 很可能成为本十年地球上增长最快的大型股之一。</blockquote> <img src=\"https://static.tigerbbs.com/3d8ba66a74371fb87c9a662943abcdd4\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\">Image source: Getty Images.<blockquote>图片来源：盖蒂图片社。</blockquote> Planet 13 Holdings<blockquote>Planet 13 控股</blockquote> Another top stock with all the tools necessary to make investors richer in December and for many years in the future is U.S.&nbsp;marijuana stock&nbsp;Planet 13 Holdings.<blockquote>美国大麻股票是另一只拥有让投资者在 12 月以及未来许多年变得更加富有所需工具的顶级股票Planet 13 控股.</blockquote> Easily the biggest objection to investing in U.S. pot stocks is the fact that Congress still hasn't enacted cannabis legalization efforts. While it would make life easier for marijuana companies if the federal government would enact reforms, the vast majority of publicly traded pot stocks are primed for success if the status quo continues. With&nbsp;36 states&nbsp;having legalized weed in some capacity, and the Department of Justice maintaining a hands-off policy, U.S. cannabis stocks like Planet 13 can bloom into successful businesses.<blockquote>对投资美国大麻股票的最大反对意见是国会仍未颁布大麻合法化措施。虽然如果联邦政府实施改革，大麻公司的日子会变得更轻松，但如果现状继续下去，绝大多数公开交易的大麻股票都将取得成功。随着36个州在某种程度上使大麻合法化，司法部保持不干涉的政策，像Planet 13这样的美国大麻股票可以蓬勃发展成成功的企业。</blockquote> For the vast majority of multi-state operators (MSOs), their strategy consists of targeting big-dollar markets and planting their proverbial flag in as many states as possible. But this isn't how Planet 13 operates. It&nbsp;gets its competitive edge&nbsp;by focusing just as much on the immersive shopping experience as it does on making a sale.<blockquote>对于绝大多数多州运营商（MSO）来说，他们的战略包括瞄准大美元市场，并在尽可能多的州插上他们众所周知的旗帜。但这不是13号行星的运作方式。它通过像关注销售一样关注身临其境的购物体验来获得竞争优势。</blockquote> For the moment, Planet 13&nbsp;has just two operating dispensaries. The first is the Las Vegas SuperStore just west of the Strip. It's 112,000 square feet in size and contains a restaurant, events center, and consumer-facing processing center. In July 2021, Planet 13 opened its Orange County SuperStore about 10 minutes from Disneyland in Santa Ana, California. It spans 55,000 square feet and features a whopping 16,500 square feet of selling space.'<blockquote>目前，行星13只有两个运营中的药房。第一个是拉斯维加斯大道西边的超市。它占地112,000平方英尺，包含一个餐厅、活动中心和面向消费者的处理中心。2021 年 7 月，Planet 13 在距离加利福尼亚州圣安娜迪士尼乐园约 10 分钟路程的橙县超市开业。它占地 55,000 平方英尺，销售空间高达 16,500 平方英尺。</blockquote> Planet 13's stores are a must-see for cannabis tourists as well as locals. In fact, significantly reduced tourist traffic to Las Vegas during the pandemic forced the company to begin focusing on local residents. With Las Vegas tourism returning to some semblance of normal, Planet 13 now has both tourist appeal and a strong local resident following.<blockquote>Planet 13的商店是大麻游客和当地人的必去之地。事实上，疫情期间前往拉斯维加斯的游客数量大幅减少，迫使该公司开始关注当地居民。随着拉斯维加斯旅游业恢复正常，星球13现在既有游客吸引力，也有强大的当地居民追随者。</blockquote> The company has also had quite a bit of success launching its own cannabis brands. According to Headset, via third-quarter commentary from Planet 13 CEO Larry Scheffler, Trendi comprises 5% of Nevada's vape sales, with HaHa edibles accounting for 14% of the Silver State's edible sales.<blockquote>该公司在推出自己的大麻品牌方面也取得了相当大的成功。根据Headset，通过Planet 13首席执行官Larry Scheffler的第三季度评论，Trendi占内华达州vape销售额的5%，哈哈食品占银州食品销售额的14%。</blockquote> With Planet 13 on the cusp of recurring profitability and more than 50% below its February high, the time for opportunistic investors to pounce is now.<blockquote>随着 Planet 13 处于经常性盈利的风口浪尖，并且比 2 月份的高点低 50% 以上，现在是机会主义投资者抓住机会的时候了。</blockquote> <img src=\"https://static.tigerbbs.com/106238ec5cefb2975d9231f3547e445c\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\">Image source: Getty Images.<blockquote>图片来源：盖蒂图片社。</blockquote> Teva Pharmaceutical Industries<blockquote>梯瓦制药工业</blockquote> As for you&nbsp;value investors, the top stock that can make you richer in December and beyond is brand-name and generic drug developer&nbsp;Teva Pharmaceutical Industries.<blockquote>对于价值投资者来说，12 月及以后最能让您更富有的股票是品牌和仿制药开发商梯瓦制药工业.</blockquote> Teva has dealt with a laundry list of bad news events over the five years. The company settled bribery charges with U.S. regulators, grossly overpaid for generic drugmaker Actavis, completely shelved its dividend, and saw its top-selling drug -- multiple sclerosis drug Copaxone -- lose patent exclusivity. But the biggest concern of late is the ongoing litigation Teva is facing over its role in the opioid crisis.<blockquote>五年来，梯瓦处理了一系列坏消息事件。该公司与美国监管机构达成了贿赂指控，为仿制药制造商 Actavis 支付了严重过高的费用，完全搁置了股息，并看到其最畅销的药物——多发性硬化症药物 Copaxone——失去了专利独占权。但最近最大的担忧是梯瓦因其在阿片类药物危机中的角色而面临的持续诉讼。</blockquote> While these are not the types of hurdles that get leaped in a single bound, Teva's CEO Kare Schultz&nbsp;has done an exemplary job&nbsp;of getting the company back on track. Schultz is a bona fide turnaround specialist who's been with the company for a little over four years. In that time, he's reduced Teva's net debt from more than $34 billion to around $22 billion. This has been accomplished by selling off non-core assets, reducing annual operating expenses by billions of dollars, and utilizing the company's bountiful operating cash flow to pay down debt. There no question that Teva is a more financially sound company now than when Schultz was first given the reins.<blockquote>虽然这些不是一次性跨越的障碍，但梯瓦的首席执行官卡雷·舒尔茨（Kare Schultz）在让公司重回正轨方面做得非常出色。舒尔茨是一位真正的扭亏为盈专家，在公司工作了四年多一点。在此期间，他将梯瓦的净债务从超过 340 亿美元减少到约 220 亿美元。这是通过出售非核心资产、减少数十亿美元的年度运营费用以及利用公司丰厚的运营现金流偿还债务来实现的。毫无疑问，梯瓦现在的财务状况比舒尔茨刚上任时更加稳健。</blockquote> Schultz is expected to play a key role in&nbsp;helping Teva navigate a sea of litigation, too. With the company focused on reducing debt, Schultz will aim to settle litigation with minimal amounts of cash. Instead, look for the company to offer free or reduced-price medication to states over roughly a decade as a way of potentially settling opioid litigation. It also doesn't hurt that a California trial found drugmakers weren't liable for the opioid epidemic. This puts added momentum in Teva's sails.<blockquote>舒尔茨预计也将在帮助梯瓦渡过诉讼之海方面发挥关键作用。由于公司专注于减少债务，舒尔茨的目标是用最少的现金解决诉讼。相反，寻找该公司在大约十年内向各州提供免费或降价药物，作为解决阿片类药物诉讼的一种潜在方式。加州的一项试验发现制药商对阿片类药物的流行没有责任，这也没有什么坏处。这为梯瓦的风帆增添了动力。</blockquote> Over the long run, Teva should be buoyed by increased usage of generics. Rapidly rising brand-name drug list prices, coupled with growing access to healthcare services, should lift Teva's generic drug pricing power and overall sales volume.<blockquote>从长远来看，仿制药使用量的增加应该会提振梯瓦。快速上涨的品牌药目录价格，加上不断增长的医疗保健服务，应该会提升梯瓦的仿制药定价权和整体销量。</blockquote> At roughly three times (yes,three times!) Wall Street's consensus forward-year earnings per share, you'd struggle to find a more deeply discounted&nbsp;drug stock&nbsp;right now.<blockquote>大约三次（是的，三次!)根据华尔街共识的未来一年每股收益，您现在很难找到折扣更大的制药股。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Top Stocks That'll Make You Richer in December (and Beyond)<blockquote>12 月（及以后）让您更富有的 3 只热门股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Top Stocks That'll Make You Richer in December (and Beyond)<blockquote>12 月（及以后）让您更富有的 3 只热门股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-12-01 22:16\n\n</h4>\n</header>\n<article>\nWe've officially hit the home stretch for what looks like another great year for the stock market. Since bottoming out in March 2020, the benchmark&nbsp;S&amp;P 500&nbsp;has been practically unstoppable. In what's become the strongest bounce-back rally from a bear-market bottom on record, the S&amp;P 500 has delivered a total return, including dividends, of 111% since March 23, 2020.<blockquote>我们已经正式进入股市又一个伟大的一年的冲刺阶段。自2020年3月触底以来，该基准标普500几乎势不可挡。自 2020 年 3 月 23 日以来，标普500从熊市底部出现了有记录以来最强劲的反弹，包括股息在内的总回报率为 111%。</blockquote> But even with the broader market a stone's throw from an all-time high, incredible deals still abound. The following three top stocks all possess attributes that can help make you richer in December, and, most importantly, well beyond.<blockquote>但即使大盘距离历史高点仅一箭之遥，令人难以置信的交易仍然比比皆是。以下三只顶级股票都拥有可以帮助您在 12 月变得更加富有的属性，最重要的是，可以帮助您在 12 月变得更加富有。</blockquote> <img src=\"https://static.tigerbbs.com/5d06d7202e9c1d1c4d748bc3e1a80774\" tg-width=\"2000\" tg-height=\"1334\" width=\"100%\" height=\"auto\">Image source: Getty Images.<blockquote>图片来源：盖蒂图片社。</blockquote> Sea Limited<blockquote>海有限公司</blockquote> For you unbridledgrowth investors, the stock that could make you a lot richer this month and well beyond is Singapore-based&nbsp;Sea Limited.<blockquote>对于你们这些肆无忌惮的成长型投资者来说，本月及以后可以让你们变得更加富有的股票是新加坡的股票海有限公司.</blockquote> Sea has had a monumental run-up since the bear-market bottom 20 months ago. Shares are up a cool 672% -- and that's after a 20% pullback from its all-time closing high on Oct. 19. With inflation picking up and coronavirus disease 2019 (COVID-19) variant concerns rearing their head, most growth stocks have taken it on the chin. But neither U.S. inflation nor COVID-19 variants are of concern to Sea Limited's three rapidly growing operating segments.<blockquote>自 20 个月前熊市底部以来，Sea 经历了巨大的上涨。该股在 10 月 19 日的历史收盘高点回调 20% 后上涨了 672%。随着通货膨胀加剧和冠状病毒疾病 2019 (COVID-19) 变种担忧抬头，大多数成长型股票都受到了影响。但美国通货膨胀和 COVID-19 变种都不是 Sea Limited 三个快速增长的运营部门的担忧。</blockquote> For the time being, the only division generating positive earnings before interest, taxes, depreciation, and amortization (EBITDA) is its mobile gaming unit, led byFree Fire. When the curtain closed on September, the company had 729 million quarterly active gamers.<blockquote>目前，唯一实现息税折旧摊销前利润 (EBITDA) 为正的部门是其移动游戏部门，由自由射击9 月份大幕落下时，该公司季度活跃玩家达到 7.29 亿。</blockquote> But it's not the number of gamers that's impressive. It's that 12.8% of these gamers (93.2 million) were paying to play. The pay-to-play conversion rate for the mobile gaming industry was closer to 2% in 2020.&nbsp; As long as Sea is generating revenue from users at a considerably higher clip than the industry average, it should command a valuation premium.<blockquote>但令人印象深刻的不是游戏玩家的数量。这些游戏玩家中有12.8%（9320万）是付费玩的。2020年，移动游戏行业的付费游戏转化率接近2%。只要Sea从用户那里获得的收入远高于行业平均水平，它就应该获得估值溢价。</blockquote> The second rapidly growing segment is digital financial services. Though this division is still relatively nascent, the number of paying mobile wallet users grew to 39.3 million in the third quarter. Since many of the regions targeted by Sea are underbanked emerging markets, offering digital financial tools that can democratize the payment process&nbsp;could be a long-term game-changer.<blockquote>第二个快速增长的细分市场是数字金融服务。尽管这一部门仍相对新生，但第三季度付费移动钱包用户数量增长至3930万。由于 Sea 的许多目标地区都是银行服务不足的新兴市场，因此提供能够使支付流程民主化的数字金融工具可能会改变游戏规则。</blockquote> But the third and&nbsp;most exciting operating segment&nbsp;is its e-commerce division, Shopee. Among downloadable shopping apps, Shopee consistently reigns supreme in Southeastern Asia. Between COVID-19 keeping people in their homes and middle-class consumers fueling buying activity in emerging market economies, Shopee is set up for success. In fact, its annual gross merchandise value (GMV) run-rate of $67.2 billion (based on third-quarter 2021 figures) is more than six times higher than the GMV the company reported in all of 2018.<blockquote>但第三个也是最令人兴奋的运营部门是其电子商务部门 Shopee。在可下载的购物应用中，Shopee在东南亚一直占据主导地位。在 COVID-19 让人们呆在家里和中产阶级消费者推动新兴市场经济体的购买活动之间，Shopee 注定要取得成功。事实上，其年度商品总价值 (GMV) 运行率为 672 亿美元（基于 2021 年第三季度数据），是该公司 2018 年全年报告的 GMV 的六倍多。</blockquote> Sea Limited could very well be one of the fastest-growing mega-cap stocks on the planet this decade.<blockquote>Sea Limited 很可能成为本十年地球上增长最快的大型股之一。</blockquote> <img src=\"https://static.tigerbbs.com/3d8ba66a74371fb87c9a662943abcdd4\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\">Image source: Getty Images.<blockquote>图片来源：盖蒂图片社。</blockquote> Planet 13 Holdings<blockquote>Planet 13 控股</blockquote> Another top stock with all the tools necessary to make investors richer in December and for many years in the future is U.S.&nbsp;marijuana stock&nbsp;Planet 13 Holdings.<blockquote>美国大麻股票是另一只拥有让投资者在 12 月以及未来许多年变得更加富有所需工具的顶级股票Planet 13 控股.</blockquote> Easily the biggest objection to investing in U.S. pot stocks is the fact that Congress still hasn't enacted cannabis legalization efforts. While it would make life easier for marijuana companies if the federal government would enact reforms, the vast majority of publicly traded pot stocks are primed for success if the status quo continues. With&nbsp;36 states&nbsp;having legalized weed in some capacity, and the Department of Justice maintaining a hands-off policy, U.S. cannabis stocks like Planet 13 can bloom into successful businesses.<blockquote>对投资美国大麻股票的最大反对意见是国会仍未颁布大麻合法化措施。虽然如果联邦政府实施改革，大麻公司的日子会变得更轻松，但如果现状继续下去，绝大多数公开交易的大麻股票都将取得成功。随着36个州在某种程度上使大麻合法化，司法部保持不干涉的政策，像Planet 13这样的美国大麻股票可以蓬勃发展成成功的企业。</blockquote> For the vast majority of multi-state operators (MSOs), their strategy consists of targeting big-dollar markets and planting their proverbial flag in as many states as possible. But this isn't how Planet 13 operates. It&nbsp;gets its competitive edge&nbsp;by focusing just as much on the immersive shopping experience as it does on making a sale.<blockquote>对于绝大多数多州运营商（MSO）来说，他们的战略包括瞄准大美元市场，并在尽可能多的州插上他们众所周知的旗帜。但这不是13号行星的运作方式。它通过像关注销售一样关注身临其境的购物体验来获得竞争优势。</blockquote> For the moment, Planet 13&nbsp;has just two operating dispensaries. The first is the Las Vegas SuperStore just west of the Strip. It's 112,000 square feet in size and contains a restaurant, events center, and consumer-facing processing center. In July 2021, Planet 13 opened its Orange County SuperStore about 10 minutes from Disneyland in Santa Ana, California. It spans 55,000 square feet and features a whopping 16,500 square feet of selling space.'<blockquote>目前，行星13只有两个运营中的药房。第一个是拉斯维加斯大道西边的超市。它占地112,000平方英尺，包含一个餐厅、活动中心和面向消费者的处理中心。2021 年 7 月，Planet 13 在距离加利福尼亚州圣安娜迪士尼乐园约 10 分钟路程的橙县超市开业。它占地 55,000 平方英尺，销售空间高达 16,500 平方英尺。</blockquote> Planet 13's stores are a must-see for cannabis tourists as well as locals. In fact, significantly reduced tourist traffic to Las Vegas during the pandemic forced the company to begin focusing on local residents. With Las Vegas tourism returning to some semblance of normal, Planet 13 now has both tourist appeal and a strong local resident following.<blockquote>Planet 13的商店是大麻游客和当地人的必去之地。事实上，疫情期间前往拉斯维加斯的游客数量大幅减少，迫使该公司开始关注当地居民。随着拉斯维加斯旅游业恢复正常，星球13现在既有游客吸引力，也有强大的当地居民追随者。</blockquote> The company has also had quite a bit of success launching its own cannabis brands. According to Headset, via third-quarter commentary from Planet 13 CEO Larry Scheffler, Trendi comprises 5% of Nevada's vape sales, with HaHa edibles accounting for 14% of the Silver State's edible sales.<blockquote>该公司在推出自己的大麻品牌方面也取得了相当大的成功。根据Headset，通过Planet 13首席执行官Larry Scheffler的第三季度评论，Trendi占内华达州vape销售额的5%，哈哈食品占银州食品销售额的14%。</blockquote> With Planet 13 on the cusp of recurring profitability and more than 50% below its February high, the time for opportunistic investors to pounce is now.<blockquote>随着 Planet 13 处于经常性盈利的风口浪尖，并且比 2 月份的高点低 50% 以上，现在是机会主义投资者抓住机会的时候了。</blockquote> <img src=\"https://static.tigerbbs.com/106238ec5cefb2975d9231f3547e445c\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\">Image source: Getty Images.<blockquote>图片来源：盖蒂图片社。</blockquote> Teva Pharmaceutical Industries<blockquote>梯瓦制药工业</blockquote> As for you&nbsp;value investors, the top stock that can make you richer in December and beyond is brand-name and generic drug developer&nbsp;Teva Pharmaceutical Industries.<blockquote>对于价值投资者来说，12 月及以后最能让您更富有的股票是品牌和仿制药开发商梯瓦制药工业.</blockquote> Teva has dealt with a laundry list of bad news events over the five years. The company settled bribery charges with U.S. regulators, grossly overpaid for generic drugmaker Actavis, completely shelved its dividend, and saw its top-selling drug -- multiple sclerosis drug Copaxone -- lose patent exclusivity. But the biggest concern of late is the ongoing litigation Teva is facing over its role in the opioid crisis.<blockquote>五年来，梯瓦处理了一系列坏消息事件。该公司与美国监管机构达成了贿赂指控，为仿制药制造商 Actavis 支付了严重过高的费用，完全搁置了股息，并看到其最畅销的药物——多发性硬化症药物 Copaxone——失去了专利独占权。但最近最大的担忧是梯瓦因其在阿片类药物危机中的角色而面临的持续诉讼。</blockquote> While these are not the types of hurdles that get leaped in a single bound, Teva's CEO Kare Schultz&nbsp;has done an exemplary job&nbsp;of getting the company back on track. Schultz is a bona fide turnaround specialist who's been with the company for a little over four years. In that time, he's reduced Teva's net debt from more than $34 billion to around $22 billion. This has been accomplished by selling off non-core assets, reducing annual operating expenses by billions of dollars, and utilizing the company's bountiful operating cash flow to pay down debt. There no question that Teva is a more financially sound company now than when Schultz was first given the reins.<blockquote>虽然这些不是一次性跨越的障碍，但梯瓦的首席执行官卡雷·舒尔茨（Kare Schultz）在让公司重回正轨方面做得非常出色。舒尔茨是一位真正的扭亏为盈专家，在公司工作了四年多一点。在此期间，他将梯瓦的净债务从超过 340 亿美元减少到约 220 亿美元。这是通过出售非核心资产、减少数十亿美元的年度运营费用以及利用公司丰厚的运营现金流偿还债务来实现的。毫无疑问，梯瓦现在的财务状况比舒尔茨刚上任时更加稳健。</blockquote> Schultz is expected to play a key role in&nbsp;helping Teva navigate a sea of litigation, too. With the company focused on reducing debt, Schultz will aim to settle litigation with minimal amounts of cash. Instead, look for the company to offer free or reduced-price medication to states over roughly a decade as a way of potentially settling opioid litigation. It also doesn't hurt that a California trial found drugmakers weren't liable for the opioid epidemic. This puts added momentum in Teva's sails.<blockquote>舒尔茨预计也将在帮助梯瓦渡过诉讼之海方面发挥关键作用。由于公司专注于减少债务，舒尔茨的目标是用最少的现金解决诉讼。相反，寻找该公司在大约十年内向各州提供免费或降价药物，作为解决阿片类药物诉讼的一种潜在方式。加州的一项试验发现制药商对阿片类药物的流行没有责任，这也没有什么坏处。这为梯瓦的风帆增添了动力。</blockquote> Over the long run, Teva should be buoyed by increased usage of generics. Rapidly rising brand-name drug list prices, coupled with growing access to healthcare services, should lift Teva's generic drug pricing power and overall sales volume.<blockquote>从长远来看，仿制药使用量的增加应该会提振梯瓦。快速上涨的品牌药目录价格，加上不断增长的医疗保健服务，应该会提升梯瓦的仿制药定价权和整体销量。</blockquote> At roughly three times (yes,three times!) Wall Street's consensus forward-year earnings per share, you'd struggle to find a more deeply discounted&nbsp;drug stock&nbsp;right now.<blockquote>大约三次（是的，三次!)根据华尔街共识的未来一年每股收益，您现在很难找到折扣更大的制药股。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/12/01/3-top-stocks-thatll-make-you-richer-in-december/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TEVA":"梯瓦制药","SE":"Sea Ltd"},"source_url":"https://www.fool.com/investing/2021/12/01/3-top-stocks-thatll-make-you-richer-in-december/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161855788","content_text":"We've officially hit the home stretch for what looks like another great year for the stock market. Since bottoming out in March 2020, the benchmark S&P 500 has been practically unstoppable. In what's become the strongest bounce-back rally from a bear-market bottom on record, the S&P 500 has delivered a total return, including dividends, of 111% since March 23, 2020.\nBut even with the broader market a stone's throw from an all-time high, incredible deals still abound. The following three top stocks all possess attributes that can help make you richer in December, and, most importantly, well beyond.\nImage source: Getty Images.\nSea Limited\nFor you unbridledgrowth investors, the stock that could make you a lot richer this month and well beyond is Singapore-based Sea Limited.\nSea has had a monumental run-up since the bear-market bottom 20 months ago. Shares are up a cool 672% -- and that's after a 20% pullback from its all-time closing high on Oct. 19. With inflation picking up and coronavirus disease 2019 (COVID-19) variant concerns rearing their head, most growth stocks have taken it on the chin. But neither U.S. inflation nor COVID-19 variants are of concern to Sea Limited's three rapidly growing operating segments.\nFor the time being, the only division generating positive earnings before interest, taxes, depreciation, and amortization (EBITDA) is its mobile gaming unit, led byFree Fire. When the curtain closed on September, the company had 729 million quarterly active gamers.\nBut it's not the number of gamers that's impressive. It's that 12.8% of these gamers (93.2 million) were paying to play. The pay-to-play conversion rate for the mobile gaming industry was closer to 2% in 2020.  As long as Sea is generating revenue from users at a considerably higher clip than the industry average, it should command a valuation premium.\nThe second rapidly growing segment is digital financial services. Though this division is still relatively nascent, the number of paying mobile wallet users grew to 39.3 million in the third quarter. Since many of the regions targeted by Sea are underbanked emerging markets, offering digital financial tools that can democratize the payment process could be a long-term game-changer.\nBut the third and most exciting operating segment is its e-commerce division, Shopee. Among downloadable shopping apps, Shopee consistently reigns supreme in Southeastern Asia. Between COVID-19 keeping people in their homes and middle-class consumers fueling buying activity in emerging market economies, Shopee is set up for success. In fact, its annual gross merchandise value (GMV) run-rate of $67.2 billion (based on third-quarter 2021 figures) is more than six times higher than the GMV the company reported in all of 2018.\nSea Limited could very well be one of the fastest-growing mega-cap stocks on the planet this decade.\nImage source: Getty Images.\nPlanet 13 Holdings\nAnother top stock with all the tools necessary to make investors richer in December and for many years in the future is U.S. marijuana stock Planet 13 Holdings.\nEasily the biggest objection to investing in U.S. pot stocks is the fact that Congress still hasn't enacted cannabis legalization efforts. While it would make life easier for marijuana companies if the federal government would enact reforms, the vast majority of publicly traded pot stocks are primed for success if the status quo continues. With 36 states having legalized weed in some capacity, and the Department of Justice maintaining a hands-off policy, U.S. cannabis stocks like Planet 13 can bloom into successful businesses.\nFor the vast majority of multi-state operators (MSOs), their strategy consists of targeting big-dollar markets and planting their proverbial flag in as many states as possible. But this isn't how Planet 13 operates. It gets its competitive edge by focusing just as much on the immersive shopping experience as it does on making a sale.\nFor the moment, Planet 13 has just two operating dispensaries. The first is the Las Vegas SuperStore just west of the Strip. It's 112,000 square feet in size and contains a restaurant, events center, and consumer-facing processing center. In July 2021, Planet 13 opened its Orange County SuperStore about 10 minutes from Disneyland in Santa Ana, California. It spans 55,000 square feet and features a whopping 16,500 square feet of selling space.'\nPlanet 13's stores are a must-see for cannabis tourists as well as locals. In fact, significantly reduced tourist traffic to Las Vegas during the pandemic forced the company to begin focusing on local residents. With Las Vegas tourism returning to some semblance of normal, Planet 13 now has both tourist appeal and a strong local resident following.\nThe company has also had quite a bit of success launching its own cannabis brands. According to Headset, via third-quarter commentary from Planet 13 CEO Larry Scheffler, Trendi comprises 5% of Nevada's vape sales, with HaHa edibles accounting for 14% of the Silver State's edible sales.\nWith Planet 13 on the cusp of recurring profitability and more than 50% below its February high, the time for opportunistic investors to pounce is now.\nImage source: Getty Images.\nTeva Pharmaceutical Industries\nAs for you value investors, the top stock that can make you richer in December and beyond is brand-name and generic drug developer Teva Pharmaceutical Industries.\nTeva has dealt with a laundry list of bad news events over the five years. The company settled bribery charges with U.S. regulators, grossly overpaid for generic drugmaker Actavis, completely shelved its dividend, and saw its top-selling drug -- multiple sclerosis drug Copaxone -- lose patent exclusivity. But the biggest concern of late is the ongoing litigation Teva is facing over its role in the opioid crisis.\nWhile these are not the types of hurdles that get leaped in a single bound, Teva's CEO Kare Schultz has done an exemplary job of getting the company back on track. Schultz is a bona fide turnaround specialist who's been with the company for a little over four years. In that time, he's reduced Teva's net debt from more than $34 billion to around $22 billion. This has been accomplished by selling off non-core assets, reducing annual operating expenses by billions of dollars, and utilizing the company's bountiful operating cash flow to pay down debt. There no question that Teva is a more financially sound company now than when Schultz was first given the reins.\nSchultz is expected to play a key role in helping Teva navigate a sea of litigation, too. With the company focused on reducing debt, Schultz will aim to settle litigation with minimal amounts of cash. Instead, look for the company to offer free or reduced-price medication to states over roughly a decade as a way of potentially settling opioid litigation. It also doesn't hurt that a California trial found drugmakers weren't liable for the opioid epidemic. This puts added momentum in Teva's sails.\nOver the long run, Teva should be buoyed by increased usage of generics. Rapidly rising brand-name drug list prices, coupled with growing access to healthcare services, should lift Teva's generic drug pricing power and overall sales volume.\nAt roughly three times (yes,three times!) Wall Street's consensus forward-year earnings per share, you'd struggle to find a more deeply discounted drug stock right now.","news_type":1,"symbols_score_info":{"PLHWF":0.9,"SE":0.9,"TEVA":0.9}},"isVote":1,"tweetType":1,"viewCount":3600,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

3 Top Stocks That'll Make You Richer in December (and Beyond)<blockquote>12 月（及以后）让您更富有的 3 只热门股票</blockquote>

评论（1）

热议股票